pillbase.ru

Bimzelx

Active substance: bimekizumab

bimekizumab

Centralised EU authorisationActive

Marketing holder: UCB Pharma S.A.  

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • Bimzelx
    INJECTION, SOLUTION · BIMEKIZUMAB 160 mg/mL
    50474-780
    UCB, Inc.
  • Bimzelx
    INJECTION, SOLUTION · BIMEKIZUMAB 320 mg/2mL
    50474-782
    UCB, Inc.
  • Bimzelx
    INJECTION, SOLUTION · BIMEKIZUMAB 320 mg/2mL
    50474-783
    UCB, Inc.
  • Bimzelx
    INJECTION, SOLUTION · BIMEKIZUMAB 160 mg/mL
    50474-781
    UCB, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-6160-77fc-b2c3-f2576ce16f52,01a1208e-6165-7c3e-bf8f-10ddbfa5f433,01a12096-047b-7271-84df-199f9f2fa52c,01a1209b-1193-7b7a-ae82-f2cf7f47b177;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005316
Registration status
Active
ATC code
L04AC
Sources
  • product · EMA · EMEA/H/C/005316 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005316 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005316 · Verified 2026-10-09